June 2, 2017 - By marketbeat
Beaconlight Capital Llc decreased Ellie Mae Inc (ELLI) stake by 80.51% reported in 2016Q4 SEC filing. Beaconlight Capital Llc sold 101,075 shares as Ellie Mae Inc (ELLI)’s stock rose 15.16%. The Beaconlight Capital Llc holds 24,470 shares with $2.05M value, down from 125,545 last quarter. Ellie Mae Inc now has $3.77B valuation. The stock increased 0.75% or $0.82 during the last trading session, reaching $110.38. About shares traded. Ellie Mae Inc (NYSE:ELLI) has risen 37.10% since June 2, 2016 and is uptrending. It has outperformed by 20.40% the S&P500.
Callahan Advisors Llc decreased Cvs Health Corporation (CVS) stake by 7.2% reported in 2016Q4 SEC filing. Callahan Advisors Llc sold 4,014 shares as Cvs Health Corporation (CVS)’s stock declined 4.23%. The Callahan Advisors Llc holds 51,723 shares with $4.08 million value, down from 55,737 last quarter. Cvs Health Corporation now has $79.82B valuation. The stock increased 1.90% or $1.46 during the last trading session, reaching $78.29. About shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 2, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.
Since February 1, 2017, it had 0 buys, and 6 sales for $22.09 million activity. $1.13M worth of CVS Health Corp (NYSE:CVS) was sold by Sussman Andrew on Monday, March 13. Roberts Jonathan C sold $4.90 million worth of stock. On Friday, March 17 the insider Boratto Eva C sold $479,908. Denton David M had sold 95,618 shares worth $7.71M on Friday, March 10. Another trade for 76,494 shares valued at $5.99M was made by MERLO LARRY J on Wednesday, February 1. Brennan Troyen A sold 23,849 shares worth $1.88 million.
Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Thursday, December 17. On Monday, August 10 the stock rating was maintained by Argus Research with “Buy”. The firm has “Outperform” rating given on Thursday, December 17 by Oppenheimer. On Thursday, June 23 the stock rating was maintained by Mizuho with “Buy”. Robert W. Baird initiated the shares of CVS in report on Friday, January 22 with “Outperform” rating. The firm has “Overweight” rating by JP Morgan given on Monday, November 2. Tigress Financial initiated the stock with “Buy” rating in Friday, April 28 report. Deutsche Bank maintained CVS Health Corp (NYSE:CVS) rating on Thursday, August 20. Deutsche Bank has “Hold” rating and $121 target. The stock of CVS Health Corp (NYSE:CVS) has “Outperform” rating given on Monday, November 2 by Oppenheimer. The stock of CVS Health Corp (NYSE:CVS) earned “Neutral” rating by Atlantic Securities on Monday, February 6.
Investors sentiment decreased to 0.74 in 2016 Q4. Its down 0.24, from 0.98 in 2016Q3. It turned negative, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Cwm Ltd owns 226 shares. Bank & Trust Of Montreal Can holds 0.36% or 4.46 million shares in its portfolio. Penobscot Inv Mgmt stated it has 1.71% of its portfolio in CVS Health Corp (NYSE:CVS). Motco owns 43,408 shares. Korea Corp holds 0.51% or 1.34M shares. Illinois-based Peak6 Investments LP has invested 0.06% in CVS Health Corp (NYSE:CVS). Eads And Heald Inv Counsel has 0.76% invested in CVS Health Corp (NYSE:CVS) for 14,202 shares. Williams Jones & Ltd invested in 79,480 shares. Stevens First Principles Investment Advsr holds 2.14% of its portfolio in CVS Health Corp (NYSE:CVS) for 39,131 shares. Hap Trading invested 0.05% of its portfolio in CVS Health Corp (NYSE:CVS). Retirement System Of Alabama holds 1.02M shares or 0.47% of its portfolio. Personal Advsrs Corporation accumulated 201,283 shares. Comm Of Virginia Va owns 90,507 shares for 1.16% of their portfolio. Aberdeen Asset Mgmt Public Limited Company Uk holds 5.20 million shares. Chevy Chase Tru accumulated 1.42M shares.
Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 earnings per share, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.34 billion for 14.94 P/E if the $1.31 EPS becomes a reality. After $1.17 actual earnings per share reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.
Callahan Advisors Llc increased Monsanto Co New Del (NYSE:MON) stake by 14,572 shares to 29,781 valued at $3.13 million in 2016Q4. It also upped Kinder Morgan Inc (NYSE:KMI) stake by 20,430 shares and now owns 388,387 shares. The Priceline Group (NASDAQ:PCLN) was raised too.
Among 14 analysts covering Elli Mae (NYSE:ELLI), 9 have Buy rating, 0 Sell and 5 Hold. Therefore 64% are positive. Elli Mae had 30 analyst reports since July 23, 2015 according to SRatingsIntel. Stephens downgraded Ellie Mae Inc (NYSE:ELLI) on Friday, April 29 to “Equal-Weight” rating. The firm has “Mkt Perform” rating by FBR Capital given on Friday, April 29. RBC Capital Markets downgraded the stock to “Sector Perform” rating in Thursday, November 17 report. Barclays Capital maintained the shares of ELLI in report on Friday, February 12 with “Overweight” rating. The rating was maintained by Roth Capital with “Buy” on Tuesday, April 26. FBR Capital maintained Ellie Mae Inc (NYSE:ELLI) rating on Friday, July 31. FBR Capital has “Mkt Perform” rating and $80 target. As per Thursday, January 12, the company rating was initiated by Morgan Stanley. The firm earned “Outperform” rating on Thursday, October 29 by Oppenheimer. The rating was maintained by FBR Capital with “Mkt Perform” on Friday, February 12. The firm earned “Buy” rating on Friday, July 31 by TH Capital.
Analysts await Ellie Mae Inc (NYSE:ELLI) to report earnings on July, 27. They expect $0.34 earnings per share, down 12.82% or $0.05 from last year’s $0.39 per share. ELLI’s profit will be $11.61 million for 81.16 P/E if the $0.34 EPS becomes a reality. After $0.03 actual earnings per share reported by Ellie Mae Inc for the previous quarter, Wall Street now forecasts 1,033.33% EPS growth.
Investors sentiment decreased to 1.15 in Q4 2016. Its down 0.21, from 1.36 in 2016Q3. It is negative, as 31 investors sold ELLI shares while 68 reduced holdings. 38 funds opened positions while 76 raised stakes. 34.78 million shares or 4.07% more from 33.42 million shares in 2016Q3 were reported. Sumitomo Mitsui Asset Limited reported 0.02% in Ellie Mae Inc (NYSE:ELLI). 16,946 are owned by Amer Grp. Weiss Multi holds 0.02% of its portfolio in Ellie Mae Inc (NYSE:ELLI) for 6,000 shares. Summit Creek Ltd has invested 1.72% in Ellie Mae Inc (NYSE:ELLI). Aqr Ltd accumulated 42,260 shares. Parametric Assocs Limited Liability Company, a Washington-based fund reported 37,013 shares. Susquehanna Grp Llp invested in 0% or 47,871 shares. The Switzerland-based Credit Suisse Ag has invested 0% in Ellie Mae Inc (NYSE:ELLI). Capstone Invest Advsr Limited Co accumulated 4,000 shares. 102,695 are owned by Picton Mahoney Asset. Ubs Asset Management Americas holds 0.01% of its portfolio in Ellie Mae Inc (NYSE:ELLI) for 140,349 shares. Dragoneer Inv Gp Inc Limited Liability reported 11,000 shares or 0.22% of all its holdings. 10,299 were reported by Navellier And Associate. Ameriprise Inc reported 49,324 shares. Ameritas Inv accumulated 2,831 shares or 0.01% of the stock.
Since December 15, 2016, it had 0 insider purchases, and 46 insider sales for $23.04 million activity. Another trade for 251 shares valued at $23,913 was made by BROWN BRIAN E. on Wednesday, March 1. $354,658 worth of Ellie Mae Inc (NYSE:ELLI) was sold by SCHREINER GATES CATHLEEN. Corr Jonathan also sold $655,796 worth of Ellie Mae Inc (NYSE:ELLI) shares. TYRRELL JOSEPH P. sold $245,248 worth of stock. Luce Edgar sold $137,649 worth of stock. BUCCELLATO CARL sold $265,346 worth of stock. SPENCER JEB S. had sold 4,000 shares worth $429,320 on Friday, May 12.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.